Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G

Journal of Infection

Volumn 63, Issue 1, 2011, Pages 8-16

  Thomsen, Reimar Wernich ^a   Riis, Anders Hammerich ^a   Kjeldsen, Sia ^a   Schønheyder, Henrik Carl ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Diabetes; Epidemiologic study; Risk; Sepsis; Streptococcal bacteraemia

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; GROUP A STREPTOCOCCAL INFECTION; GROUP B STREPTOCOCCAL INFECTION; GROUP G STREPTOCOCCAL INFECTION; HUMAN; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; REGRESSION ANALYSIS; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP G; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DENMARK; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; YOUNG ADULT;

EID: 79959602669     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.05.013     Document Type: Article

References (46)

1. Ekelund K., Skinhoj P., Madsen J., Konradsen H.B. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 2005, 11:569-576.
2. Laupland K.B., Ross T., Church D.L., Gregson D.B. Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin Microbiol Infect 2006, 12:224-230.
3. Skoff T.H., Farley M.M., Petit S., Craig A.S., Schaffner W., Gershman K., et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009, 49:85-92.
4. Lamagni T.L., Darenberg J., Luca-Harari B., Siljander T., Efstratiou A., Henriques-Normark B., et al. Epidemiology of severe streptococcus pyogenes disease in Europe. J Clin Microbiol 2008, 46:2359-2367.
5. O'Brien K.L., Beall B., Barrett N.L., Cieslak P.R., Reingold A., Farley M.M., et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002, 35:268-276.
6. Tyrrell G.J., Lovgren M., Kress B., Grimsrud K. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol 2005, 43:1678-1683.
7. Sendi P., Johansson L., Norrby-Teglund A. Invasive group B streptococcal disease in non-pregnant adults. Infection 2008, 36:100-111.
8. Blancas D., Santin M., Olmo M., Alcaide F., Carratala J., Gudiol F. Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome. Eur J Clin Microbiol Infect Dis 2004, 23:168-173.
9. Farley M.M., Harvey R.C., Stull T., Smith J.D., Schuchat A., Wenger J.D., et al. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med 1993, 328:1807-1811.
10. Matsubara K., Yamamoto G. Invasive group B streptococcal infections in a tertiary care hospital between 1998 and 2007 in Japan. Int J Infect Dis 2009, 13:679-684.
11. Munoz P., Llancaqueo A., Rodriguez-Creixems M., Pelaez T., Martin L., Bouza E. Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med 1997, 157:213-216.
12. Opal S.M., Cross A., Palmer M., Almazan R. Group B streptococcal sepsis in adults and infants. Contrasts and comparisons. Arch Intern Med 1988, 148:641-645.
13. Schwartz B., Schuchat A., Oxtoby M.J., Cochi S.L., Hightower A., Broome C.V. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA 1991, 266:1112-1114.
14. Tyrrell G.J., Senzilet L.D., Spika J.S., Kertesz D.A., Alagaratnam M., Lovgren M., et al. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study-1996. J Infect Dis 2000, 182:168-173. Sentinel Health Unit Surveillance System Site Coordinators.
15. Perovic O., Crewe-Brown H.H., Khoosal M., Karstaedt A.S. Invasive group B streptococcal disease in nonpregnant adults. Eur J Clin Microbiol Infect Dis 1999, 18:362-364.
16. Factor S.H., Levine O.S., Schwartz B., Harrison L.H., Farley M.M., McGeer A., et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003, 9:970-977.
17. Jackson L.A., Hilsdon R., Farley M.M., Harrison L.H., Reingold A.L., Plikaytis B.D., et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995, 123:415-420.
18. Green A., Christian H.N., Pramming S.K. The changing world demography of type 2 diabetes. Diabetes Metab Res Rev 2003, 19:3-7.
19. Nielsen G.L., Sørensen H.T., Zhou W., Steffensen F.H., Olsen J. The pharmacoepidemiologic prescription database of north Jutland - a valid tool in pharmacoepidemiological research. Int J Risk Saf Med 1997, 10:203-205.
20. Thomsen R.W., Hundborg H.H., Johnsen S.P., Pedersen L., Sorensen H.T., Schonheyder H.C., et al. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med 2006, 34:1080-1086.
21. Jensen U.S., Knudsen J.D., Ostergaard C., Gradel K.O., Frimodt-Moller N., Schonheyder H.C. Recurrent bacteraemia: a 10-year regional population-based study of clinical and microbiological risk factors. J Infect 2010, 60:191-199.
22. Schønheyder H.C., Søgaard M. Existing data sources for clinical epidemiology: the north Denmark bacteremia research database. Clin Epidemiol 2010, 2:171-178.
23. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 1988, 1988(16):128-140.
24. Siegman-Igra Y., Fourer B., Orni-Wasserlauf R., Golan Y., Noy A., Schwartz D., et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002, 34:1431-1439.
25. Kornum J.B., Thomsen R.W., Riis A., Lervang H.H., Schonheyder H.C., Sorensen H.T. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008, 31:1541-1545.
26. Olivarius N.F., Hollnagel H., Krasnik A., Pedersen P.A., Thorsen H. The Danish National Health Service Register. A tool for primary health care research. Dan Med Bull 1997, 44:449-453.
27. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
28. Thomsen R.W., Hundborg H.H., Lervang H.H., Johnsen S.P., Schonheyder H.C., Sorensen H.T. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care 2004, 27:1143-1147.
29. Cohen-Poradosu R., Jaffe J., Lavi D., Grisariu-Greenzaid S., Nir-Paz R., Valinsky L., et al. Group G streptococcal bacteremia in Jerusalem. Emerg Infect Dis 2004, 10:1455-1460.
30. Hindsholm M., Schonheyder H.C. Clinical presentation and outcome of bacteraemia caused by beta-haemolytic streptococci serogroup G. APMIS 2002, 110:554-558.
31. Tee W.S., Lieu P.K., Ngan C.C. Epidemiology of beta-haemolytic group G streptococcal bacteraemia in Singapore (1996 to 1998). Ann Acad Med Singapore 2002, 31:86-91.
32. Wong S.S., Lin Y.S., Mathew L., Rajagopal L., Sepkowitz D. Increase in group G streptococcal infections in a community hospital, New York, USA. Emerg Infect Dis 2009, 15:991-993.
33. Woo P.C., Fung A.M., Lau S.K., Wong S.S., Yuen K.Y. Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing. J Clin Microbiol 2001, 39:3147-3155.
34. Cox N.H. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol 2006, 155:947-950.
35. Lipsky B., Tabak Y., Johannes R., Vo L., Hyde L., Weigelt J. Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 2010, 53:914-923.
36. Cheer K., Shearman C., Jude E.B. Managing complications of the diabetic foot. BMJ 2009, 339:b4905.
37. Thomsen R.W., Kasatpibal N., Riis A., Norgaard M., Sorensen H.T. The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study. J Gen Intern Med 2008, 23:1407-1413.
38. Shah B.R., Hux J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003, 26:510-513.
39. Peleg A.Y., Weerarathna T., McCarthy J.S., Davis T.M.E. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes-Metabolism Res Rev 2007, 23:3-13.
40. Stegenga M.E., van der Crabben S.N., Blumer R.M.E., Levi M., Meijers J.C.M., Serlie M.J., et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 2008, 112:82-89.
41. Murray P.R., Rosenthal K.S., Pfaller M.A. Streptococcus. Medical microbiology 2009, 225-242. Mosby. P.R. Murray (Ed.).
42. Sanden A.K., Johansen M.B., Pedersen L., Lervang H.H., Schonheyder H.C., Thomsen R.W. Change from oral antidiabetic therapy to insulin and risk of urinary tract infections in type 2 diabetic patients: a population-based prescription study. J Diabetes Complications 2010, 24:375-381.
43. Thomsen R.W., Hundborg H.H., Lervang H.H., Johnsen S.P., Schonheyder H.C., Sorensen H.T. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis 2005, 40:628-631.
44. Krogh-Madsen R., Moller K., Dela F., Kronborg G., Jauffred S., Pedersen B.K. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2004, 286:E766-E772.
45. Kornum J.B., Thomsen R.W., Riis A., Lervang H.H., Schonheyder H.C., Sorensen H.T. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 2007, 30:2251-2257.
46. Yende S., van der Poll T., Lee M., Huang D.T., Newman A.B., Kong L., et al. The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax 2010, 65:870-877.